The EndoFLUXX^TM reflux control valve developed by Vysera Biomedical, and partnered with Merit Medical Endotek^TM for commercial release, has been proven clinically to be superior to existing market solutions for reflux control. The EndoFLUXX^TM reflux control valve differs from competitor solutions in that it prevents reflux while allowing the patient to belch and vomit. Other products on the market are ineffective when the patient belches or vomits; they often malfunction leading to reflux of stomach contents and increased patient pain and discomfort.

The EndoFLUXX^TM Reflux Control System is CE marked and approved for patients with both malignant and benign esophageal strictures for controlling reflux and the prevention of aspiration pneumonia. Patient data from both patient groups reports as much as 80% improvement in reflux.

For queries on acquiring EndoFLUXX^TM Reflux Control System product, please contact Merit Medical’s European Customer Service by Country;